Mr. Speaker, my question is directed to the Minister of Health.
Fifteen thousand Canadians suffer from multiple sclerosis. In the U.S., the drug Betaseron has been used to treat MS for over a year. Betaseron is currently being reviewed by the health protection branch and can only be obtained under the emergency drug release program at a cost of over $17,000.
Can the minister provide information on when Betaseron will be made available to Canadian MS victims at a price they can afford?